Promising techniques for breast cancer detection, diagnosis, and staging using non-ionizing radiation imaging techniques

Physica Medica

Volumn 21, Issue SUPPL. 1, 2006, Pages 7-10

  Park, Jinha M ^a   Ikeda, Debra M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Breast; Breast cancer; Magnetic resonance; Optical imaging near infrared; Quantum dots; Reporter probes

Indexed keywords

ANTINEOPLASTIC AGENT; CADMIUM; CONTRAST MEDIUM; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; NANOPARTICLE; PEPTIDE DERIVATIVE; QUANTUM DOT; SELENIDE; TELLURIUM DERIVATIVE;

BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CANCER TISSUE; CONFERENCE PAPER; ECHOMAMMOGRAPHY; FALSE POSITIVE RESULT; HIGH RISK PATIENT; HUMAN; IMAGING SYSTEM; IONIZING RADIATION; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TISSUE STRUCTURE; TREATMENT RESPONSE; VALIDATION STUDY; X RAY;

EID: 34247222025     PISSN: 11201797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1120-1797(06)80014-1     Document Type: Conference Paper

References (40)

1. Boetes C, Barentsz J O, Mus R D, van der Sluis R F, van Erning L J, Hendriks J H, et alii. MR characterization of suspicious breast lesions with a gadolinium- enhanced TurboFLASH subtraction technique. Radiology 1994; 193 (3): 777-81.
2. Harms S E, Flamig D P, Hesley K L, Meiches M D, Jensen R A, Evans W P, et alii. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187(2) :493-501.
3. Berg W A, Gutierrez L, Nessaiver M S, Carter W B, Bhargavan M, Lewis R S, et alii. Diagnostic Accuracy of Mammography, Clinical Examination, US, and MR Imaging in Preoperative Assessment of Breast Cancer. Radiology 2004.
4. (ACR) ACoR. ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. Reston, VA: American College of Radiology; 2003.
5. Ikeda D M, Birdwell R L, Daniel B L. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection. Magn Reson Imaging Clin N Am 2001; 9(2): 345-56, vii.
6. Qayyum A, Birdwell R L, Daniel B L, Nowels K W, Jeffrey S S, Agoston T A, et alii. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 2002; 178 (5): 1227-32.
7. Yeh E D, Slanetz P J, Edmister W B, Talele A, Monticciolo D, Kopans D B. Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J 2003; 9(1): 13-8.
8. Nunes L W, Schnall M D, Siegelman E S, et alii. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR 1997 (169): 409-415.
9. Kuhl CK, Schild H H. Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging 2000; 12 (6): 965-74.
10. Kelcz F, Santyr G E, Cron G O, Mongin S J. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging 1996; 6 (5): 743-52.
11. Kuhl C K, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et alii. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999; 211 (1): 101-10.
12. Kinkel K, Helbich T H, Esserman L J, Barclay J, Schwerin E H, Sickles E A, et alii. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol 2000; 175 (1): 35-43.
13. Morris E A, Liberman L, Dershaw D D, Kaplan J B, LaTrenta L R, Abramson A F, et alii. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol 2002; 178 (5): 1211-20.
14. Liberman L, Morris E A, Dershaw D D, Thornton C M, Van Zee K J, Tan L K. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol 2003; 181 (5): 1283-93.
15. Daniel B L, Birdwell R L, Ikeda D M, Jeffrey S S, Black J W, Block W F, et alii. Breast lesion localization: a freehand, interactive MR imaging-guided technique. Radiology 1998; 207 (2): 455-63.
16. Lee C H. Problem solving M R imaging of the breast. Radiol Clin North Am 2004; 42 (5): 919-34, vii.
17. Ikeda D M, Baker D R, Daniel B L. Magnetic resonance imaging of breast cancer: clinical indications and breast MRI reporting system. J Magn Reson Imaging 2000; 12(6): 975-83.
18. Tjalma W A, Verslegers I O. Nipple discharge and the value of M R imaging. Eur J Obstet Gynecol Reprod Biol 2004; 115 (2): 234-6.
19. Offodile R S, Daniel B L, Jeffrey S S, Wapnir I, Dirbas F M, Ikeda D M. Magnetic resonance imaging of suspicious breast masses seen on one mammographic view. Breast J 2004; 10 (5): 416-22.
20. Warner E, Plewes D B, Hill K A, Causer P A, Zubovits J T, Jong R A, et alii. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. Jama 2004; 292 (11): 1317-25.
21. Liberman L, Morris E A, Kim C M, Kaplan J B, Abramson A F, Menell J H, et alii. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 2003; 180 (2): 333-41.
22. Boppart S A, Luo W, Marks D L, Singletary K W. Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer. Breast Cancer Res Treat 2004; 84 (2): 85-97.
23. Cerussi A E, Berger A J, Bevilacqua F, Shah N, Jakubowski D, Butler J, et alii. Sources of absorption and scattering contrast for near-infrared optical mammography. Acad Radiol 2001; 8(3): 11-8.
24. Shah N, Cerussi A E, Jakubowski D, Hsiang D, Butler J, Tromberg B J. The role of diffuse optical spectroscopy in the clinical management of breast cancer. Dis Markers 2003; 19 (2-3): 95-105.
25. Shah N, Cerussi A, Eker C, Espinoza J, Butler J, Fishkin J, et alii. Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci USA 2001; 98 (8): 4420-5.
26. Pogue B W, Jiang S, Dehghani H, Kogel C, Soho S, Srinivasan S, et alii. Characterization of hemoglobin, water, and NIR scattering in breast tissue: analysis of intersubject variability and menstrual cycle changes. J Biomed Opt 2004; 9(3): 541-52.
27. Jiang H, Xu Y, Iftimia N, Eggert J, Klove K, Baron L, et alii. Three-dimensional optical tomographic imaging of breast in a human subject. IEEE Trans Med Imaging 2001; 20 (12): 1334-40.
28. Ntziachristos V, Chance B. Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res 2001; 3 (1): 41-6.
29. Ntziachristos V, Yodh A G, Schnall M D, Chance B. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 2002; 4(4): 347-54.
30. Andreev V G, Karabutov A A, Oraevsky A A. Detection of ultrawide-band ultrasound pulses in optoacoustic tomography. IEEE Trans Ultrason Ferroelectr Freq Control 2003; 50 (10): 1383-90.
31. Ebert B, Sukowski U, Grosenick D, Wabnitz H, Moesta K T, Licha K, et alii. Near-infrared fluorescent dyes for enhanced contrast in optical mammography: phantom experiments. J Biomed Opt 2001; 6 (2): 134-40.
32. Copland J A, Eghtedari M, Popov V L, Kotov N, Mamedova N, Motamedi M, et alii. Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography. Mol Imaging Biol 2004; 6 (5): 341-9.
33. Boehm T, Hochmuth A, Malich A, Reichenbach J R, Fleck M, Kaiser W A. Contrast-enhanced near-infrared laser mammography with a prototype breast scanner: feasibility study with tissue phantoms and preliminary results of imaging experimental tumors. Invest Radiol 2001; 36 (10): 573-81.
34. Wu X, Liu H, Liu J, Haley K N, Treadway J A, Larson J P, et alii. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003; 21 (1): 41-6.
35. Rice B W, Cable M D, Nelson M B. In vivo imaging of light-emitting probes. J Biomed Opt 2001; 6 (4): 432-40.
36. Massoud T F, Gambhir S S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17 (5): 545-80.
37. Hilger I, Leistner Y, Berndt A, Fritsche C, Haas K M, Kosmehl H, et al. Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol 2004; 14 (6): 1124-9.
38. Mahmood U, Tung C H, Bogdanov A Jr., Weissleder R. Near-infrared optical imaging of protease activity for tumor detection. Radiology 1999; 213 (3): 866-70
39. Ntziachristos V, Tung C H, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002; 8 (7): 757-60.
40. Bremer C, Ntziachristos V, Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 2003; 13(2): 231-43.